These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy. Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056 [TBL] [Abstract][Full Text] [Related]
3. Heparin-like effect in postcardiotomy extracorporeal membrane oxygenation patients. Ranucci M; Baryshnikova E; Isgrò G; Carlucci C; Cotza M; Carboni G; Ballotta A Crit Care; 2014 Sep; 18(5):504. PubMed ID: 25189998 [TBL] [Abstract][Full Text] [Related]
4. Bivalirudin May Reduce the Need for Red Blood Cell Transfusion in Pediatric Cardiac Patients on Extracorporeal Membrane Oxygenation. Machado DS; Garvan C; Philip J; Harrington D; Spiess B; Kelly B; Campbell CT; Pelletier JPR; Islam S; Peek GJ; Bleiweis MS ASAIO J; 2021 Jun; 67(6):688-696. PubMed ID: 33031157 [TBL] [Abstract][Full Text] [Related]
5. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO). Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation. Seelhammer TG; Bohman JK; Schulte PJ; Hanson AC; Aganga DO Crit Care Med; 2021 Sep; 49(9):1481-1492. PubMed ID: 33870916 [TBL] [Abstract][Full Text] [Related]
7. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study. Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625 [TBL] [Abstract][Full Text] [Related]
9. Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support. Campbell CT; Diaz L; Kelly B Ann Pharmacother; 2021 Jan; 55(1):59-64. PubMed ID: 32590908 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation. Seelhammer TG; Brokmeier HM; Hamzah M; Wieruszewski PM Crit Care Med; 2023 May; 51(5):e115-e121. PubMed ID: 36853326 [TBL] [Abstract][Full Text] [Related]
11. Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review. Netley J; Roy J; Greenlee J; Hart S; Todt M; Statz B J Extra Corpor Technol; 2018 Sep; 50(3):161-166. PubMed ID: 30250342 [TBL] [Abstract][Full Text] [Related]
12. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study. Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413 [TBL] [Abstract][Full Text] [Related]
13. Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high-volume center. Schill MR; Douds MT; Burns EL; Lahart MA; Said AS; Abarbanell AM Artif Organs; 2021 Jan; 45(1):15-21. PubMed ID: 32557733 [TBL] [Abstract][Full Text] [Related]
14. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation. Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330 [TBL] [Abstract][Full Text] [Related]
15. Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis. Li DH; Sun MW; Zhang JC; Zhang C; Deng L; Jiang H Thromb Res; 2022 Feb; 210():53-62. PubMed ID: 35007937 [TBL] [Abstract][Full Text] [Related]